ThinkEquity Initiates Coverage on Inverness Medical (IMA) with a Buy
IMA Hot Sheet
Rating Summary:0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 18 | New: 27
ThinkEquity initiates coverage on Inverness Medical (NYSE: IMA) with a Buy. Price target $42.
To see more analyst ratings on IMA Click Here.
Inverness Medical Innovations, Inc. is a global developer, manufacturer and marketer of advanced consumer and professional medical diagnostic products.
To see more analyst ratings on IMA Click Here.
Inverness Medical Innovations, Inc. is a global developer, manufacturer and marketer of advanced consumer and professional medical diagnostic products.
You May Also Be Interested In
- UPDATE: UBS Starts PSS World Medical (PSSI) at Buy; Get Past Tough Flu Comps; Shares Look Undervalued
- Topeka Capital Starts Green Plains Renewable Energy (GPRE) at Buy
- JPMorgan Starts Ares Commercial (ACRE) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
